These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

312 related items for PubMed ID: 16505320

  • 1. Effects of intermittent levetiracetam dosing in a patient with refractory daily seizures.
    Friedman D, French JA.
    Neurology; 2006 Feb 28; 66(4):590-1. PubMed ID: 16505320
    [Abstract] [Full Text] [Related]

  • 2. Add-on levetiracetam in children and adolescents with refractory epilepsy: results of an open-label multi-centre study.
    Callenbach PM, Arts WF, ten Houten R, Augustijn P, Gunning WB, Peeters EA, Weber AM, Stroink H, Geerts Y, Geerts AT, Brouwer OF.
    Eur J Paediatr Neurol; 2008 Jul 28; 12(4):321-7. PubMed ID: 17950011
    [Abstract] [Full Text] [Related]

  • 3. Preliminary efficacy of levetiracetam in monotherapy.
    Ben-Menachem E.
    Epileptic Disord; 2003 May 28; 5 Suppl 1():S51-5. PubMed ID: 12915342
    [Abstract] [Full Text] [Related]

  • 4. Levetiracetam in clinical practice: long-term experience in patients with refractory epilepsy referred to a tertiary epilepsy center.
    Bootsma HP, Ricker L, Diepman L, Gehring J, Hulsman J, Lambrechts D, Leenen L, Majoie M, Schellekens A, de Krom M, Aldenkamp AP.
    Epilepsy Behav; 2007 Mar 28; 10(2):296-303. PubMed ID: 17317325
    [Abstract] [Full Text] [Related]

  • 5. Efficacy and safety of levetiracetam as an add-on therapy in children aged less than 4 years with refractory epilepsy.
    Li S, Cao J, Xiao N, Cai F.
    J Child Neurol; 2010 May 28; 25(5):609-13. PubMed ID: 19779208
    [Abstract] [Full Text] [Related]

  • 6. Adjunctive levetiracetam in infants and young children with refractory partial-onset seizures.
    Piña-Garza JE, Nordli DR, Rating D, Yang H, Schiemann-Delgado J, Duncan B, Levetiracetam N01009 Study Group.
    Epilepsia; 2009 May 28; 50(5):1141-9. PubMed ID: 19243423
    [Abstract] [Full Text] [Related]

  • 7. Levetiracetam: preliminary efficacy in generalized seizures.
    Kasteleijn-Nolst Trenité DG, Hirsch E.
    Epileptic Disord; 2003 May 28; 5 Suppl 1():S39-44. PubMed ID: 12915340
    [Abstract] [Full Text] [Related]

  • 8. Efficacy of levetiracetam in the treatment of drug-resistant Rett syndrome.
    Specchio N, Balestri M, Striano P, Cilio MR, Nardello R, Patanè S, Margiotta ML, D'Orsi G, Striano S, Russo S, Specchio LM, Cusmai R, Fusco L, Vigevano F.
    Epilepsy Res; 2010 Feb 28; 88(2-3):112-7. PubMed ID: 19914805
    [Abstract] [Full Text] [Related]

  • 9. Use of levetiracetam in hospitalized patients.
    Falip M, Carreño M, Amaro S, Donaire A, Delgado R, Toledo M, Maestro I.
    Epilepsia; 2006 Dec 28; 47(12):2186-8. PubMed ID: 17201722
    [Abstract] [Full Text] [Related]

  • 10. Once-daily extended-release levetiracetam as adjunctive treatment of partial-onset seizures in patients with epilepsy: a double-blind, randomized, placebo-controlled trial.
    Peltola J, Coetzee C, Jiménez F, Litovchenko T, Ramaratnam S, Zaslavaskiy L, Lu ZS, Sykes DM, Levetiracetam XR N01235 Study Group.
    Epilepsia; 2009 Mar 28; 50(3):406-14. PubMed ID: 19317886
    [Abstract] [Full Text] [Related]

  • 11. Efficacy of levetiracetam in children with refractory epilepsy as an add-on trial.
    Tonekaboni SH, Ghazavi M, Karimzadeh P, Mahvelati F, Ghofrani M.
    Epilepsy Res; 2010 Aug 28; 90(3):273-7. PubMed ID: 20619606
    [Abstract] [Full Text] [Related]

  • 12. Role of levetiracetam in the treatment of epilepsy.
    Brodie MJ, French JA.
    Epileptic Disord; 2003 May 28; 5 Suppl 1():S65-72. PubMed ID: 12915344
    [Abstract] [Full Text] [Related]

  • 13. Neurocognitive effects of adjunctive levetiracetam in children with partial-onset seizures: a randomized, double-blind, placebo-controlled, noninferiority trial.
    Levisohn PM, Mintz M, Hunter SJ, Yang H, Jones J, N01103 Levetiracetam Study Group.
    Epilepsia; 2009 Nov 28; 50(11):2377-89. PubMed ID: 19702752
    [Abstract] [Full Text] [Related]

  • 14. The SKATE study: an open-label community-based study of levetiracetam as add-on therapy for adults with uncontrolled partial epilepsy.
    Steinhoff BJ, Somerville ER, Van Paesschen W, Ryvlin P, Schelstraete I.
    Epilepsy Res; 2007 Aug 28; 76(1):6-14. PubMed ID: 17681453
    [Abstract] [Full Text] [Related]

  • 15. Multicenter double-blind, randomized, placebo-controlled trial of levetiracetam as add-on therapy in Chinese patients with refractory partial-onset seizures.
    Wu XY, Hong Z, Wu X, Wu LW, Wang XF, Zhou D, Zhao ZX, Lv CZ.
    Epilepsia; 2009 Mar 28; 50(3):398-405. PubMed ID: 18657175
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Long-term experience with levetiracetam.
    Abou-Khalil B, Lazenby B.
    Epileptic Disord; 2003 May 28; 5 Suppl 1():S33-7. PubMed ID: 12915339
    [Abstract] [Full Text] [Related]

  • 18. Benefit of combination therapy in epilepsy: a review of the preclinical evidence with levetiracetam.
    Kaminski RM, Matagne A, Patsalos PN, Klitgaard H.
    Epilepsia; 2009 Mar 28; 50(3):387-97. PubMed ID: 18627416
    [Abstract] [Full Text] [Related]

  • 19. Levetiracetam induces a rapid and sustained reduction of generalized spike-wave and clinical absence.
    Cavitt J, Privitera M.
    Arch Neurol; 2004 Oct 28; 61(10):1604-7. PubMed ID: 15477517
    [Abstract] [Full Text] [Related]

  • 20. Dose-response population analysis of levetiracetam add-on treatment in refractory epileptic patients with partial onset seizures.
    Snoeck E, Stockis A.
    Epilepsy Res; 2007 Mar 28; 73(3):284-91. PubMed ID: 17196793
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.